Synjardy tablets receive FDA approval for adults with type 2 diabetes
27 August 2015 | By Nick Jackson
Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...
List view / Grid view
News
HRA Pharma launches ellaOne® website for pharmacists
27 August 2015 | By Nick Jackson
HRA Pharma UK and Ireland has announced the launch of ellaonepharmacist.co.uk, a brand new website designed specifically for healthcare professionals which provides an educational resource for ellaOne® (30mg ulipristal acetate) accessible anytime.
Ablynx announces half-year results for 2015
27 August 2015 | By Nick Jackson
Ablynx has announced its business update and results for the six-month period ending 30 June 2015...
Combination of Roche medicines Cotellic and Zelboraf approved in Switzerland for the treatment of patients with advanced melanoma
27 August 2015 | By Nick Jackson
New treatment option for patients with difficult-to-treat form of skin cancer has shown improved treatment outcomes...
FDA approves Praluent for the treatment of high LDL cholesterol
26 August 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Praluent (alirocumab) Injection - the first and only PCSK9 inhibitor approved in the US...
Alvogen to acquire four Pfizer products for the US market
26 August 2015 | By Victoria White
Alvogen is to acquire four pharmaceutical products from Pfizer, strengthening Alvogen’s commercial platform in the US market...
Largest Phase 3 trial of Ibrance in early breast cancer opens
26 August 2015 | By Victoria White
Alliance Foundation Trials, the Austrian Breast & Colorectal Cancer Study Group and Pfizer have launched the Palbociclib Collaborative Adjuvant Study...
NICE recommends vedolizumab for Crohn’s Disease
26 August 2015 | By Victoria White
NICE has recommended Vedolizumab, the first gut-selective treatment for Crohn's Disease, for use on the NHS, recognising the innovation of the treatment...
NICE recommends edoxaban for deep vein thrombosis
26 August 2015 | By Victoria White
NICE has recommended once-daily edoxaban for the treatment and prevention of recurrent DVT and pulmonary embolism, saying the drug is cost-effective for the NHS...
Operational cost savings for Perrigo UK
25 August 2015 | By CI Precision
Perrigo UK recently installed three SP-4C tablet and capsule sample weight checkers from specialist weighing equipment manufacturer CI Precision...
Study raises doubt about health benefits of omega-3
25 August 2015 | By Victoria White
A large clinical trial by researchers at the National Institutes of Health has found that omega-3 supplements did not slow cognitive decline in older people...
Brazil’s pharmaceutical market to continue to prosper
25 August 2015 | By Victoria White
Brazil's pharmaceutical market will expand to reach approximately $47.9 billion by 2020, according to research and consulting firm GlobalData...
FDA approves label expansion for Promacta
25 August 2015 | By Victoria White
The FDA has approved a label expansion for Promacta to treat low blood platelet count in paediatric patients with chronic immune thrombocytopenic purpura...
Disappointing results for liraglutide in type 1 diabetes
25 August 2015 | By Victoria White
Novo Nordisk has announced headline results from the final Phase 3a trial with liraglutide as adjunct therapy to insulin for people with type 1 diabetes...
Data findings highlight common misconceptions about concussion
24 August 2015 | By Victoria White
New data from Abbott's Concussion IQ Survey reveals that many adults lack basic understanding about concussion signs, symptoms, risk and treatment...
